- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT06034392
Estudo e repositório cardíaco do aplicativo CHAMP (CHAMP)
Estudo cardíaco do aplicativo CHAMP: avaliação de funções de software para monitoramento assíncrono de crianças com doença cardíaca congênita complexa em ambiente doméstico e repositório de dados
This is a multi-site research study with an optional research repository that will consist of clinically derived data and photographic or video images of patients in the home setting with complex health conditions to evaluate the safety and efficacy of the CHAMP® software platform, with data and photographic or video images input and/or uploaded by the parent or other legally authorized representative (LAR) of patients with complex congenital heart disease as a target population.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Study objectives
- To evaluate whether data collection and transmission through the CHAMP software platform improves communication between health care providers and parents/LAR that positively affects the care of children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated
- To determine the accuracy of data obtained regarding observation by parent or caregiver of the condition of children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated.
- To evaluate the use of the CHAMP App for clinical purposes, including user satisfaction with the data entry, parental self-management, and transmission capabilities.
- To evaluate the real-world performance analytics (RWPA) of the CHAMP software platform for transfer of parent-entered data for children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated.
Endpoints
- To demonstrate that parents and caregivers for children with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated can accurately identify and transmit to healthcare providers specific health-related data including intake of food, fluids and mediations; output, including urination, defecation, and vomiting; weight; vital signs including oxygen saturation as measured by pulse oximetry; heart rate as measured either by a heart rate monitor or manually by the parent or caregiver; and temperature, measured by a reliable thermometer; and the value and reliability of videos provided by parents and caregivers regarding behavior of pediatric study participants for use in evaluating participant's health status.
- To demonstrate that data obtained through the use of devices such as pulse oximeters, as entered into the app by parents and caregivers, provide valuable information regarding the health status of children with Complex Diagnoses in a home setting.
- To demonstrate characteristics of CHAMP through real world health analytics (RWHA), user experience analytics (UX), and product performance analytics (PPA).
The study duration is open-ended for safety, effectiveness, and performance of the CHAMP app. Unless consent is withdrawn, data will be kept and used for data analysis and, if consented to the research repository for multi-site research purposes indefinitely. At age 18, previously pediatric patients may be approached for reconsent.
Tipo de estudo
Inscrição (Estimado)
Contactos e Locais
Locais de estudo
-
-
District of Columbia
-
Washington D.C., District of Columbia, Estados Unidos, 20010
- Children's National Hospital
-
-
Florida
-
Miami, Florida, Estados Unidos, 33155
- Nicklaus Variety Children's Hospital
-
-
Louisiana
-
New Orleans, Louisiana, Estados Unidos, 70118
- Children's Hospital New Orleans
-
-
Missouri
-
Kansas City, Missouri, Estados Unidos, 64108
- Children's Mercy Hospital
-
-
Ohio
-
Cincinnati, Ohio, Estados Unidos, 45219
- Cincinnati Children's Hospital Medical Center
-
Columbus, Ohio, Estados Unidos, 43205
- Nationwide Children's Hospital
-
-
Texas
-
Forth Worth, Texas, Estados Unidos, 76104
- Cook's Children's
-
Houston, Texas, Estados Unidos, 77030
- Children's Memorial Hermann Hospital
-
-
Utah
-
Salt Lake City, Utah, Estados Unidos, 84108
- Primary Children's Hospital/University of Utah
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Pediatric patients with complex congenital heart disease in which asynchronous monitoring in the home setting is indicated in the home setting through a multi-regional approach.
Parents who utilize their CHAMP App and the healthcare team that log-in are also part of the CHAMP App study.
Descrição
Inclusion Criteria:
- Age 0-17 years with a parent/Legally authorized representative
- Diagnosed with a complex health condition in which asynchronous monitoring in the home setting is appropriate.
- Pediatric patient's cardiac care team has decided that the patient's treatment plan may benefit from remote home monitoring.
- Institution that the subject is followed through clinically has been an approved as site for the CHAMP app study with Children's Mercy Kansas City.
Adult participants
- Parents/Legally authorized representatives of pediatric subject.
- Healthcare team users at an institution that is an approved site for the CHAMP app Study with Children's Mercy Kansas City.
Exclusion Criteria:
- Inability to be discharged to care in the home setting.
- Those not meeting the above inclusion criteria.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Modelos de observação: COHORT
- Perspectivas de Tempo: OTHER
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Human factors/usability engineering: Login failures
Prazo: Over a 3 month period
|
Rate of attempts of log-in failures |
Over a 3 month period
|
|
Human factors/usability engineering: Imprecision
Prazo: Over a 3 month period
|
Rate of data values reported with imprecision |
Over a 3 month period
|
|
Clinical Safety: Anticipated adverse events
Prazo: Over a 3 month period
|
Anticipated Adverse event rates |
Over a 3 month period
|
|
Clinical Safety: Event resolution- anticipated
Prazo: Time in days, reported over the last 3 months
|
Time to resolve anticipated adverse events |
Time in days, reported over the last 3 months
|
|
Clinical Safety: Unanticipated Adverse events
Prazo: Time in days, reported over the last 3 months
|
Unanticipated adverse event rates |
Time in days, reported over the last 3 months
|
|
Clinical Safety: Event resolution- unanticipated
Prazo: Time in days, reported over the last 3 months
|
Time to resolve unanticipated adverse events |
Time in days, reported over the last 3 months
|
|
Health Benefits: Adherence
Prazo: Measurement of adherence to daily data entry per each patient/parent over 3 month period on non-hospitalized days, during the study period
|
Rate of adherence to daily data entry |
Measurement of adherence to daily data entry per each patient/parent over 3 month period on non-hospitalized days, during the study period
|
|
User Satisfaction: Complaints
Prazo: Over a 3 month period
|
Complaint rates via the healthcare team web portal |
Over a 3 month period
|
|
User Satisfaction CHAMP Video
Prazo: through study completion, an average of 9 months
|
Feedback from healthcare team will be received via treatment endpoint survey questions. Likert scale questions 1-strongly disagree to 5 strongly agree (Using CHAMP videos for the interstage monitoring of this patient improved clinical decisions for the home monitoring team). Available to put in comments. |
through study completion, an average of 9 months
|
|
User Satisfaction: Communication
Prazo: through study completion, an average of 9 months
|
Feedback from healthcare team will be received via treatment endpoint survey questions Likert scale questions 1-strongly disagree to 5 strongly agree ( Using CHAMP for the interstage monitoring of this patient improved communication with the parents at home.) Available to put in comments. |
through study completion, an average of 9 months
|
|
User Engagement
Prazo: Over a 3 month perriod
|
Total number of registered users (Active, treatment endpoint reached) and data totals per parent entered measure. De-identified Demographics and age areas utilization -Utilization across the number of pediatric sites, healthcare teams |
Over a 3 month perriod
|
|
CHAMP app performance: Downtime
Prazo: Over a 3 month period
|
Product Performance Analytics measured through Any system downtime |
Over a 3 month period
|
|
CHAMP app performance: Cybersecurity
Prazo: Over a 3 month period
|
Product Performance Analytics measured through Any reported breaches |
Over a 3 month period
|
|
CHAMP app performance
Prazo: Quarterly review of CHAMP App Performance will be measure over the preceding 3 months for frequency of changes required
|
Product Performance Analytics measured through --Bug/defect rate or Version failure rates |
Quarterly review of CHAMP App Performance will be measure over the preceding 3 months for frequency of changes required
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Lori Erickson, PhD, Director, Remote Health Solutions Children's Mercy
Publicações e links úteis
Publicações Gerais
- Shirali G, Erickson L, Apperson J, Goggin K, Williams D, Reid K, Bradley-Ewing A, Tucker D, Bingler M, Spertus J, Rabbitt L, Stroup R. Harnessing Teams and Technology to Improve Outcomes in Infants With Single Ventricle. Circ Cardiovasc Qual Outcomes. 2016 May;9(3):303-11. doi: 10.1161/CIRCOUTCOMES.115.002452. Epub 2016 May 10.
- Bingler M, Erickson LA, Reid KJ, Lee B, O'Brien J, Apperson J, Goggin K, Shirali G. Interstage Outcomes in Infants With Single Ventricle Heart Disease Comparing Home Monitoring Technology to Three-Ring Binder Documentation: A Randomized Crossover Study. World J Pediatr Congenit Heart Surg. 2018 May;9(3):305-314. doi: 10.1177/2150135118762401.
- Aly DM, Erickson LA, Hancock H, Apperson JW, Gaddis M, Shirali G, Goudar S. Ability of Video Telemetry to Predict Unplanned Hospital Admissions for Single Ventricle Infants. J Am Heart Assoc. 2021 Aug 17;10(16):e020851. doi: 10.1161/JAHA.121.020851. Epub 2021 Aug 7.
- Erickson LA, Emerson A, Russell CL. Parental mobile health adherence to symptom home monitoring for infants with congenital heart disease during the single ventricle interstage period: A concept analysis. J Spec Pediatr Nurs. 2020 Oct;25(4):e12303. doi: 10.1111/jspn.12303. Epub 2020 Jul 14.
- Patel PS, Shah SK, Feldman K, Hancock HS, Moehlmann ML, Ricketts A, Files MD, McFarland C, Erickson L, Romans RA. Associations of Home Monitoring Data to Interventional Catheterization for Infants with Recurrent Coarctation of the Aorta and Hypoplastic Left Heart Syndrome. Pediatr Cardiol. 2023 Oct;44(7):1462-1470. doi: 10.1007/s00246-023-03224-8. Epub 2023 Jul 8.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 15030113CMH
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .